Table 1.
Key data sources by measure, year and coverage
| Measure | Time period | Year | Coverage | References |
| Prevalence | 20-year prevalence | Up to the end of 2010 | UK | 14 |
| Incidence | Annual | 2014 | UK | 9–12 34 |
| Incidence by stage at diagnosis | Annual | 2014 | England and Northern Ireland (cervix) | 12 13 |
| Mortality | Annual | 2014 (Northern Ireland 2013) | UK | 10 18 19 |
| Survival all stages combined | 1 and 5 years | Predicted for adults diagnosed in 2015 | England | 35 |
| Survival by stage | 1 year | Diagnosed 2014 followed up to 2015 | England | 36 |
| Diagnosed 2002–2009 (cervix) | Northern Ireland | 12 | ||
| Survival by stage | 5 years | Diagnosed 2006–2010 (renal cell kidney cancer) | England | 37 |
| Diagnosed 2002–2006 (prostate, breast and uterus) | Former Anglia Cancer Network | 22 | ||
| Diagnosed 2002–2009 (cervix) and 2005–2009 (colorectal) | Northern Ireland | 12 |
CRUK, Cancer Reseach UK; ISD, Information Services Divisionsion Scotland; NCIN, National Cancer Intelligence Network; NCRAS, National Cancer Registration and Analysis Service; NICR, Northern Ireland Cancer Registry; ONS, Office for National Statistics; WCISU, Welsh Cancer Intelligence & Surveillance Unit.